Stage 01
Special Offer
£499+ VAT
Book by 30 November 2026

Global Vaccine Leadership Summit 2027
Hilton London Olympia, United Kingdom
Co-located with Pharmacovigilance Europe 2027 www.pveurope.com
People. Partnerships. Progress.
01 About this edition
On 20 May 2027, the Global Vaccine Leadership Summit convenes in London as one of two global editions — an invitation-led gathering organised by Graviton International.
The London edition is co-located with Pharmacovigilance Europe 2027 (www.pveurope.com) at Hilton London Olympia.
In a single, focused day, the London edition examines the priorities shaping vaccines today: scientific innovation and development, regulation and vaccine safety, pandemic preparedness, and equitable access and delivery. Sessions connect research, policy and industry perspectives, with an emphasis on decisions and practical next steps.
The day is designed for senior leaders from industry, government, regulators, public health, academia and biotechnology. Delegates can expect keynotes, leadership discussions and panels, with time built in for the one-to-one conversations that matter between sessions.
02 Why attend
A closed-door, invitation-led format, with the time and space for exchange that larger congresses cannot offer.
Senior leaders from across sectors, convened at a scale that allows genuine exchange.
An invitation-led delegation, so the people you meet are the people you need to meet.
Government, academia, industry and global health in the same conversation.
Sessions grounded in the science shaping vaccine innovation and preparedness.
A forum linked to its sister edition, building relationships across continents.
Structured time between sessions for the conversations that move work forward.
03 Programme
Thursday20 May 2027
Indicative structure Session times and titles are placeholders and will change.
Full programme coming soon.
04 Speakers
Chaired by Dr Bassam Hallis OBE of the UK Health Security Agency, with speakers from the UK and India confirmed. Further speakers will be announced as they are confirmed.

Summit Chair
Deputy Director, Head of Vaccine Development & Evaluation Centre, UK Health Security Agency
United Kingdom
Dr Bassam Hallis OBE is Deputy Director and lead for the Vaccine Development and Evaluation Centre at the UK Health Security Agency.
Bassam has over 35 years’ experience working with the public sector, industry and academia in the development and evaluation of vaccines and therapeutics. He provides scientific and operational leadership in the evaluation of immunogenicity and efficacy of vaccines and therapeutics for high-consequence infectious diseases, including influenza and COVID-19. His research and expertise span the life cycle of countermeasures, from early-stage antigen discovery to post-licensure, and incorporate in vitro and in vivo activities at containment levels 2, 3 and 4.
Bassam collaborates across academia, industry and the not-for-profit sector to develop pandemic preparedness capabilities, and supports the development of scientific capabilities globally, especially in the Global South.

Professor of Paediatric Immunology and Infectious Diseases, NIHR
United Kingdom
Professor Saul Faust is an NIHR Senior Investigator and Co-National Specialty Lead for Children, and Professor of Paediatric Immunology and Infectious Diseases. His research focuses on clinical trials of vaccines and antimicrobials in children and adults. He is Director of the NIHR Southampton Clinical Research Facility, Co-Director of the NIHR Wessex Commercial Research Delivery Centre, National Co-Clinical Lead for Infection Vaccines in the NIHR Vaccine Innovation Pathway, and NIHR RDN South Central Co-Health and Care Director (Medical).
Head Medico Marketing, International Business Division, Serum Institute of India
India
Dr. Mohanish Vaidya is Head of Medico Marketing for the International Business Division at Serum Institute of India Pvt. Ltd., based in Pune, Maharashtra.

05 Exhibition & partnership
Four levels of partnership, each designed around meaningful access rather than volume.
| Benefits | IHeadline Partner | IIGold Partner | IIISilver Partner | IVExhibition Partner |
|---|---|---|---|---|
| Brand visibility | To be confirmed | To be confirmed | To be confirmed | To be confirmed |
| Delegate access | To be confirmed | To be confirmed | To be confirmed | To be confirmed |
| Exhibition presence | To be confirmed | To be confirmed | To be confirmed | To be confirmed |
| Thought-leadership opportunities | To be confirmed | To be confirmed | To be confirmed | To be confirmed |
| Networking | To be confirmed | To be confirmed | To be confirmed | To be confirmed |
| Digital visibility | To be confirmed | To be confirmed | To be confirmed | To be confirmed |
Benefits are being finalised. The prospectus sets out full details for each level.
Request the partnership prospectus06 Delegate passes
One delegate rate for everyone — the earlier you book, the less you pay. Prices exclude VAT.
Special Offer
Ends 30 November 2026
Stage 01
£499+ VAT
Book by 30 November 2026
Stage 02
£699+ VAT
Book by 31 January 2027
Stage 03
£799+ VAT
Book by 31 March 2027
Stage 04
£999+ VAT
From 1 April 2027
All prices are per delegate and exclude VAT at 20%. Places are limited.
Book your pass07 Travel & stay
Venue
Hilton London Olympia
Where to stay
Listing not showing? Open the hotel map in a new tab.

Also joining us in Boston?
Boston
15–16 September 2027
Explore BostonBrochure
The delegate brochure and partnership prospectus for the London edition. Complete a short form and the brochure will be sent to you.
Request the brochure (opens in a new tab)Opens a short Google Form in a new tab.